The FDA proposes changes to mammography standards for first time in more than 20 years
These are the first changes to the regulation of mammography screening in more than 20 years, aimed at improving quality and modernizing breast cancer screening, FDA Commissioner Dr. Scott Gottlieb said.The key changes include providing patients with information about breast density, in the form of a letter, with screening results.Mammograms of dense breasts are known to be more difficult to read and interpret.
"Mammography is the best tool in determining if a woman has breast cancer," Gottlieb said. Breast cancer is the second most common cancer among American women, after skin cancer, and the second leading cause of cancer deaths after lung cancer. According to the National Cancer Institute, more than 260,000 women in the United States were diagnosed with breast cancer in 2018, and more than 40,920 women died from breast cancer that year.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA says cybersecurity vulnerabilities found in some Medtronic devicesThe U.S. Food and Drug Administration (FDA) on Thursday said cybersecurity vulne...
Consulte Mais informação »
Outgoing FDA chief: Altria bait-and-switched me with $12.8 billion Juul investmentFood and Drug Administration (FDA) Commissioner Scott Gottlieb said on Tuesday that tobacco giant Altria went back on its promise to clamp down on vape pods with its $12.8 billion investment in e-cigarette decacorn Juul Labs.
Consulte Mais informação »
Jazz Pharma's sleep disorder treatment gets FDA nodThe U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's t...
Consulte Mais informação »
FDA-approved 'breakthrough' heart failure device improves heart function in patients with late-stage diseaseA new device on the market for patients with heart failure is the first device in cardiology to receive a “breakthrough” designation by the Food and Drug Administration.
Consulte Mais informação »
FDA takes up decades-long debate over breast implant safety
Consulte Mais informação »
FDA approves new device for treating patients with chronic heart failureThe Food and Drug Administration approved a breakthrough medical device last week for patients suffering from chronic, hard-to-treat heart failure.
Consulte Mais informação »
Women, doctors speak about breast implant illnesses at FDA hearingThe FDA is reviewing the safety of breast implants used by millions of American women at a 2-day hearing about their long-term potential health effects.
Consulte Mais informação »
Flood of CBD products puts FDA in a bindCBD blurs the regulatory line between drugs and supplements, testing how much the government can police health claims
Consulte Mais informação »
‘I was not warned’ - Women who say they were sickened by breast implants demand FDA actionAt a hearing, patients, advocates, say the Food and Drug Administration should take steps to warn patients about risks of implants and take some devices off the market.
Consulte Mais informação »